Early-Onset Group B Streptococcal Infection After a Combined Maternal and Neonatal Group B Streptococcal Chemoprophylaxis Strategy
Authors:
- 1 March 2003
- journal article
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 111 (3) , 541-547
Abstract
Objective. In January 1995, a combined maternal and neonatal protocol for prevention of early-onset group B streptococcal (GBS) infection was implemented that consisted of a risk factor-based approach for maternal intrapartum chemoprophylaxis using ampicillin combined with a single intramuscular dose of penicillin given to all newborns within 1 hour of delivery. The objective of this study was to review the cases of early-onset GBS infections that occurred from 1995 to 1999 to identify factors associated with their continued occurrence despite implementation of a GBS chemoprophylaxis protocol. Methods. Infants ≤72 hours of age with early-onset GBS infection born at Parkland Memorial Hospital in Dallas from January 1995 to December 1999 were identified through a prospective laboratory-based surveillance system. Maternal and infant medical records were reviewed for clinical and demographic data. Results. There were 32 cases (0.47/1000 live births) of early-onset GBS infection for the 5-year period. This represented a 76% reduction compared with the rate from 1986 to 1994 (1.95/1000), when there was no protocol for GBS chemoprophylaxis. Thirteen cases (41%) did not have any identifiable maternal risk factor. Of the 19 cases (59%) with risk factors, maternal intrapartum fever was the most frequent (15 [79%]), followed by prematurity (6 [32%]) and prolonged rupture of membranes (6 [32%]). Among the 19 mothers with risk factors, 15 (79%) mothers received intrapartum chemoprophylaxis, and 12 (80%) of the 15 mothers had intrapartum fever. Only 33% of mothers with risk factors received ≥2 doses of intrapartum chemoprophylaxis, and among those with intrapartum fever, 25% received ≥2 doses. None of the 32 infants with early-onset GBS infection received the combination of intrapartum ampicillin and postnatal penicillin. Conclusions. A combined obstetric and neonatal chemoprophylaxis protocol significantly reduced early-onset GBS infection. Maternal intrapartum fever was the most frequent risk factor associated with failure of chemoprophylaxis.Keywords
This publication has 24 references indexed in Scilit:
- Reducing Neonatal Group B Streptococcal DiseaseNew England Journal of Medicine, 2000
- Group B Streptococcal Disease in the Era of Intrapartum Antibiotic ProphylaxisNew England Journal of Medicine, 2000
- Risk Factors and Opportunities for Prevention of Early-onset Neonatal Sepsis: A Multicenter Case-Control StudyPediatrics, 2000
- Opportunities for Prevention of Perinatal Group B Streptococcal Disease: A Multistate Surveillance AnalysisObstetrics & Gynecology, 1997
- Prevention of early-onset group b streptococcal disease: Another look at single-dose penicillin at birthObstetrics & Gynecology, 1996
- Group B Streptococcus (GBS) and Neonatal Infections: The Case for Intrapartum ChemoprophylaxisAustralian and New Zealand Journal of Obstetrics and Gynaecology, 1991
- Prevention of Early-Onset Neonatal Group B Streptococcal Disease with Selective Intrapartum ChemoprophylaxisNew England Journal of Medicine, 1986
- Selective Intrapartum Chemoprophylaxis of Neonatal Group B Streptococcal Early-Onset Disease. I. Epidemiologic RationaleThe Journal of Infectious Diseases, 1983
- SINGLE-DOSE PENICILLIN PROPHYLAXIS OF NEONATAL GROUP-B STREPTOCOCCAL DISEASEThe Lancet, 1982
- Single-Dose Penicillin Prophylaxis against Neonatal Group B Streptococcal InfectionsNew England Journal of Medicine, 1980